Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. J. P. Huntly
Imatinib Improves but May Not Fully Reverse the Poor Prognosis of Patients With CML With Derivative Chromosome 9 Deletions
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
Imatinib Mesylate Therapy May Overcome the Poor Prognostic Significance of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
ABL-BCR Expression Does Not Correlate With Deletions on the Derivative Chromosome 9 or Survival in Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Duplication of Isoderivative Ph Chromosome With Tp53 Deletion in a Case of Imatinib Resistant CML
International Journal of Human Genetics
Genetics
The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Nuclear LEF1/TCF4 Correlate With Poor Prognosis but Not With Nuclear Β-Catenin in Cerebral Metastasis of Lung Adenocarcinomas
Clinical and Experimental Metastasis
Medicine
Cancer Research
Oncology
CML: Langzeitresultate Zum Imatinib-Stopp
Im Focus Onkologie
EZH2 Overexpression Is Associated With Poor Prognosis in Patients With Glioma
Oncotarget
Oncology
Downregulation of ALDOB Is Associated With Poor Prognosis of Patients With Gastric Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Overexpression of VEGF-C and MMP-9 Predicts Poor Prognosis in Kazakh Patients With Esophageal Squamous Cell Carcinoma
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
